Pirazofurin or pyrazofurin
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111651This classification denotes a pyrimidine antagonist and orotidylate decarboxylase inhibitor with the molecular formula C9H13N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B15044GQZ, chemically known as 1h-pyrazole-5-carboxamide, 4-hydroxy-3-beta-d-ribofuranosyl- but generally known as pirazofurin, which bears US NIH Compound Identifier 5360877. European Medicines Agency schedules Pirazofurin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09897MIG. The term PIRAZOFURIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). PIRAZOFURIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Pirazofurin or pyrazofurin bears US NLM identifiers UMLS ID C0072661 and NCI Concept Code C1208. SMILES: C(C1C(C(C(O1)C2=NNC(=C(N)O)C2=O)O)O)O.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.